ReviewFrontiers in immunology2026

Immune checkpoint inhibitors in dMMR-MSI-H colorectal cancer: rationale, progress and prospects.

Guangre Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.